• Thumbnail for Trametinib
    Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma and glioma. It is a MEK inhibitor...
    15 KB (976 words) - 17:10, 20 October 2024
  • Thumbnail for Dabrafenib
    rash, joint pain, fever and tiredness. When taken in combination with trametinib, the most common side effects include fever, tiredness, nausea, chills...
    16 KB (1,122 words) - 03:21, 24 April 2024
  • Thumbnail for Melanoma
    BRAF inhibitors, such as vemurafenib and dabrafenib and a MEK inhibitor trametinib are the most effective, approved treatments for BRAF positive melanoma...
    156 KB (16,312 words) - 20:10, 3 January 2025
  • Thumbnail for Nodular melanoma
    BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. Important prognosis factors for nodular melanoma include: Thickness Ulceration...
    4 KB (386 words) - 15:36, 21 May 2024
  • Thumbnail for Lung cancer
    of NSCLC) can be treated by dabrafenib combined with the MEK inhibitor trametinib; those with activated ROS1 (around 1% of NSCLC) can be inhibited by crizotinib...
    90 KB (9,784 words) - 12:48, 29 November 2024
  • Thumbnail for Navitoclax
    evaluated as a combination treatment against solid tumors together with trametinib in a clinical trial sponsored by the National Cancer Institute. In this...
    13 KB (1,295 words) - 07:06, 24 November 2024
  • Thumbnail for Targeted therapy
    metastatic melanoma that harbors BRAF V600E mutation MEK inhibitors (trametinib, MEK162) are used in experiments, often in combination with BRAF inhibitors...
    20 KB (2,234 words) - 01:21, 22 July 2024
  • Thumbnail for Acral lentiginous melanoma
    BRAF inhibitors, such as vemurafenib and dabrafenib; or a MEK inhibitor trametinib may be used. When arising in the nailbed of a digit, the evidence suggests...
    24 KB (2,383 words) - 15:31, 14 November 2024
  • Thumbnail for Anaplastic thyroid cancer
    thyroid cancer harboring such mutations. The combination of dabrafenib and trametinib has shown significant increases in overall survival and has been approved...
    20 KB (2,157 words) - 22:06, 3 January 2025
  • Rosuvastatin Crestor 1.37 in hemodialysis patients Lisinopril Prinivil and others 1.38 Ivacaftor Kalydeco 2.2–2.9 Trametinib Mekinist 6.0 at 2 mg once daily...
    4 KB (432 words) - 05:16, 4 July 2024
  • for medical use in the United States in September 2020. Dabrafenib and trametinib have been approved as tissue-agnostic drugs for solid tumors that are...
    7 KB (597 words) - 15:52, 6 August 2024
  • Fecher, Leslie A.; et al. (2012). "Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial"....
    3 KB (296 words) - 17:06, 14 September 2023
  • Lilly/Boehringer) tralokinumab (INN) tralonide (INN) tramadol (INN) tramazoline (INN) trametinib (USAN, INN) tramiprosate (USAN) Trancopal Trandate trandolapril (INN)...
    12 KB (563 words) - 00:00, 1 October 2024
  • Thumbnail for Myasthenia gravis
    are tyrosine kinase inhibitors that may also cause MG), dabrafenib, and trametinib; 3) antipsychotic drugs, i.e., chlorpromazine, pimozide, thioridazine...
    81 KB (8,706 words) - 09:28, 4 January 2025
  • Ceritinib L01ED03 Alectinib L01ED04 Brigatinib L01ED05 Lorlatinib L01EE01 Trametinib L01EE02 Cobimetinib L01EE03 Binimetinib L01EE04 Selumetinib L01EE05 Mirdametinib...
    13 KB (935 words) - 04:36, 23 December 2024
  • cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found that acupoint-moxibustion has a role in...
    24 KB (3,068 words) - 07:21, 7 June 2024
  • Thumbnail for Vemurafenib
    trial results compared vemurafenib with the combination of dabrafenib and trametinib for metastatic melanoma. Vemurafenib was approved in the United States...
    21 KB (1,815 words) - 16:50, 24 November 2024
  • include uveal melanoma (failed), and differentiated thyroid carcinoma. Trametinib (GSK1120212), FDA-approved to treat BRAF-mutated melanoma. Also studied...
    6 KB (719 words) - 23:12, 12 May 2024
  • Thumbnail for Lymphangiectasia
    including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. Dog breeds commonly affected by lymphangiectasia and/or protein-losing...
    10 KB (1,002 words) - 06:53, 6 January 2024
  • Pacritinib Ruxolitinib MAP2K (MEK) Binimetinib Cobimetinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's (BTK) Acalabrutinib...
    12 KB (821 words) - 06:14, 23 December 2024
  • Thumbnail for Skin cancer
    BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. In February 2024, the Food and Drug Administration approved the first...
    58 KB (6,508 words) - 20:52, 6 December 2024
  • Thumbnail for Hairy cell leukemia
    can be tried. Or a BRAF inhibitor can be restarted plus MEK inhibitors trametinib or cobimetinib. Interferon-alpha is an immune system hormone that is very...
    53 KB (6,579 words) - 17:52, 2 January 2025
  • Thumbnail for H. Lee Moffitt Cancer Center & Research Institute
    at Moffitt Cancer Center discovered two monotherapy drugs – Mekinist (trametinib) and Tafinlar (dabrafenib) – can be safely combined to overcome or delay...
    30 KB (2,979 words) - 06:17, 17 November 2024
  • including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. The disease was first reported in 1961 by T.A. Waldmann. He described...
    8 KB (821 words) - 04:51, 21 November 2024
  • Thumbnail for U0126
    Drug Evaluation and Research (2023-03-31). "FDA approves dabrafenib with trametinib for pediatric patients with low-grade glioma with a BRAF V600E mutation"...
    9 KB (766 words) - 05:02, 14 December 2024
  • interstellar comet 2I/Borisov. 30 September – By combining doses of lithium, trametinib and rapamycin into a single treatment, researchers extend the lifespan...
    257 KB (24,667 words) - 23:33, 29 November 2024
  • Thumbnail for Polypoid melanoma
    inhibitors, such as vemurafenib and dabrafenib; and an MEK inhibitor trametinib. Melanoma List of cutaneous conditions James, William D.; Berger, Timothy...
    5 KB (346 words) - 10:52, 28 March 2024
  • Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Trametinib Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Dabrafenib...
    42 KB (240 words) - 07:06, 3 January 2025
  • human patients with a kidney disease. By combining doses of lithium, trametinib and rapamycin into a single treatment, researchers extend the lifespan...
    203 KB (18,823 words) - 07:55, 26 December 2024
  • Thumbnail for ALK inhibitor
    ALK inhibitors with MEK inhibitors: brigatinib+binimetinib, ceritinib+trametinib, and alectinib+cobimetinib. Results for the last two are expected around...
    17 KB (1,951 words) - 10:39, 25 January 2024